Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Employment test 1 - 10 employees
Company dna avidity ip ltd
no operation time available
Headquarter in Cambridge and 2 offices
active in Legal Services

We have observed 12 EP applications Anthony Paul Breen has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 15, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12800813

HIGH THROUGH-PUT SCREENING IN SKIN FIBROBLASTS WITH AN ALPHA-SYNUCLEIN TRIPLICATION

IPC classification:
C12N 5/071, C12Q 1/68, G01N 33/50
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP12839719

USE OF FUNGICIDES IN LIQUID SYSTEMS

IPC classification:
C12N 1/12, C12N 1/13, C12Q 1/68
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12845681

PLANT-BASED EGG SUBSTITUTE AND METHOD OF MANUFACTURE

IPC classification:
A23L 1/10, A23L 1/20
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP12785566

ASSAY TO DETERMINE LRRK2 ACTIVITY IN PARKINSON'S DISEASE

IPC classification:
C07K 16/40, C07K 16/44, G01N 33/53, G01N 33/573, G01N 33/577
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12825596

STENT SYSTEM, DEPLOYMENT APPARATUS AND METHOD FOR BIFURCATED LESION

IPC classification:
A61F 2/82, A61F 2/95
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP13749526

BIOMASS YIELD GENES

IPC classification:
C12N 1/13, C12N 1/21, C12N 15/29, C12N 15/31, C12N 15/52
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13754200

LIPID AND GROWTH TRAIT GENES

IPC classification:
C12N 15/31, C12R 1/89
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP12807105

COMPOSITIONS AND METHODS FOR TREATMENT OF SYMPTOMS IN PARKINSON'S DISEASE PATIENTS

IPC classification:
A61K 9/22, A61K 9/48, A61K 31/465, A61P 25/16
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP14180831

Antibody-mediated disruption of quorum sensing in bacteria

IPC classification:
A61K 38/12, A61K 39/00, C07K 7/56, C07K 16/12, C07K 16/44
Applicant:
The Scripps Research Institute
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
PATENT GRANTED
EP14188785

Monoclonal antibodies to Fibroblast Growth Factor receptor 2

IPC classification:
A61K 39/395, C12P 21/08
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP13830477

BIFURCATED DUAL-BALLOON CATHETER SYSTEM FOR BIFURCATED VESSELS

IPC classification:
A61F 2/954, A61F 2/958
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP11854829

4-(ORTHO-SUBSTITUTED-PHENYL)-5-OXO-2,5-DIHYDRO-1H-PYRROLE COMPOUNDS AS PESTICIDES

IPC classification:
A01N 43/40, C07D 401/04, C07D 401/06
Applicant:
Syngenta Participations AG
Agent:
Syngenta International AG
Agent:
Anthony Paul Breen, Syngenta Ltd
Status:
PATENT GRANTED

Please Sign in to use this feature